Literature DB >> 21943860

Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.

Stephen D Lawn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21943860     DOI： 10.5588/ijtld.11.0407

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  3 in total

Review 1.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

2.  Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.

Authors:  Arnold Bainomugisa; Eddie Wampande; Chris Muchwa; Joseph Akol; Paul Mubiri; Henry Ssenyungule; Enock Matovu; Sam Ogwang; Moses Joloba
Journal:  BMC Infect Dis       Date:  2015-04-14       Impact factor: 3.090

3.  Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis.

Authors:  Monde Muyoyeta; Nkatya Chanda Kasese; Deborah Milimo; Isaac Mushanga; Mapopa Ndhlovu; Nathan Kapata; Maureen Moyo-Chilufya; Helen Ayles
Journal:  BMC Infect Dis       Date:  2017-04-24       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.